A monoclonal antibody to domain 5 of high molecular weight kininogen (HK) is therapeutic in a rodent model of rheumatoid arthritis.

被引：0
|
作者：
Espinola, R [1 ]
Uknis, A [1 ]
Sainz, I [1 ]
Isordia-Salas, I [1 ]
Agelan, A [1 ]
DeLa Cadena, R [1 ]
Pixley, R [1 ]
Colman, RW [1 ]
机构：
[1] Temple Univ, Sch Med, Sol Sherry Thrombosis Res Ctr, Philadelphia, PA 19122 USA
来源：
BLOOD | 2003年 / 102卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3858
引用
收藏
页码：39B / 39B
页数：1
相关论文
共 50 条
  • [31] Domain 5 of high molecular weight kininogen (kininostatin) downregulates endothelial cell proliferation and migration and inhibits angiogenesis.
    Colman, RW
    Jameson, B
    Mousa, SA
    FASEB JOURNAL, 1999, 13 (07): : A1407 - A1407
  • [32] Domain 5 of cleaved high-molecular-weight-kininogen inhibits endothelial cell migration and proliferation through Akt
    Katkade, VB
    Soyombo, AA
    Isordia-Salas, I
    Bradford, HN
    Colman, RW
    Panetti, TS
    MOLECULAR BIOLOGY OF THE CELL, 2004, 15 : 228A - 228A
  • [33] High molecular weight kininogen deficient patient with a single basepair deletion in the surface binding region of domain 5.
    Krijanovski, Y
    Mahdi, F
    Proulle, V
    Dreyfus, M
    Kerbirious-Nabias, D
    Schmaier, AH
    BLOOD, 2001, 98 (11) : 530A - 531A
  • [34] The high-molecular-weight kininogen Domain 5 is an intrinsically unstructured protein and its interaction with ferritin is metal mediated
    Huhn, Annissa J.
    Parsonage, Derek
    Horita, David A.
    Torti, Frank M.
    Torti, Suzy V.
    Hollis, Thomas
    PROTEIN SCIENCE, 2014, 23 (08) : 1013 - 1022
  • [35] INCREASED HIGH MOLECULAR WEIGHT ADIPONECTIN AND LEAN MASS DURING TOCILIZUMAB TREATMENT IN PATIENTS WITH RHEUMATOID ARTHRITIS. A 12 MONTHMULTICENTER STUDY
    Eric, Toussirot
    Marotte, Hubert
    Mulleman, Denis
    Cormier, Gregoire
    Coury-Lucas, Fabienne
    Gaudin, Philippe
    Dernis, Emmanuelle
    Bonnet, Christine
    Damade, Richard
    Grauer, Jean Luc
    Ait-Abdesselam, Tassadit
    Karras, Caroline Guillibert
    Liote, Frederic
    Hilliquin, Pascal
    Sacchi, Antoinette
    Berthelot, Jean Marie
    Puyraveau, Marc
    Dumoulin, Gilles
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1157 - 1157
  • [36] Domain 5 of high molecular weight kininogen (kininostatin) down-regulates endothelial cell proliferation and migration and inhibits angiogenesis
    Colman, RW
    Jameson, BA
    Lin, YZ
    Johnson, D
    Mousa, SA
    BLOOD, 2000, 95 (02) : 543 - 550
  • [37] Domain 5 of high molecular weight kininogen inhibits proliferation of human colon cancer cells by interfering with Cdc2
    Bior, AD
    Eltahir, AY
    Colman, RW
    FASEB JOURNAL, 2005, 19 (05): : A1506 - A1506
  • [38] MONOCLONAL-ANTIBODY TO HUMAN HIGH-MOLECULAR-WEIGHT KININOGEN RECOGNIZES ITS PREKALLIKREIN BINDING-SITE AND INHIBITS ITS COAGULANT ACTIVITY
    REDDIGARI, SR
    KAPLAN, AP
    BLOOD, 1989, 74 (02) : 695 - 702
  • [39] Peptides derived from high molecular weight kininogen (HK) domains 3 and 5 inhibit endothelial cell proliferation and induce endothelial cell apoptosis.
    Zhang, JC
    Juarez, J
    Shaw, DE
    Mazar, AP
    McCrae, KR
    BLOOD, 2000, 96 (11) : 41A - 41A
  • [40] Identification of peptide sequences in high molecular weight kininogen domain 5 responsible for modulation of heparin accelerated inhibition of thrombin by antithrombin.
    Pixley, RA
    Lin, YZ
    Colman, RW
    BLOOD, 2000, 96 (11) : 47A - 47A
12345